PER 1.16% 8.5¢ percheron therapeutics limited

melbourne presentation, page-3

  1. 14,981 Posts.
    lightbulb Created with Sketch. 51
    Nice work Megagene79

    I found the results of the 20 year study done on those dwarfism subjects really interesting and obviously really supporting and validating the tie in between IGF levels and diseases (hence confirming the potential for ATL1103)

    Also found the instances of lower IGF levels in the centurian age group folks interesting and didn't realise the significance until then.

    And that it's all genetic in that those who lived to 100 years old often did so, as well as family members, due to the common link to IGF levels again, and most were of modest to average height as a basic common. Can't remember the group, but was a socially isolated one from memory

    He said he couldn't see ATL1103 being approved as a treatment for "treating old age" but it was a likely pleasant side effect of those treated with the drug, to treat other disorders, which I found quite amusing (and wishful thinking)

    Typing this as I try and keep one ear on a conference call, so excuse any grammatical shortcomings

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
-0.001(1.16%)
Mkt cap ! $88.12M
Open High Low Value Volume
8.6¢ 8.8¢ 8.5¢ $290.3K 3.355M

Buyers (Bids)

No. Vol. Price($)
4 322623 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.8¢ 227962 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.